How to Get Mounjaro in the UK: Prescription, Price and Eligibility

If you want the short version: in the UK, Mounjaro (tirzepatide) is a prescription-only medicine, so you can only get it after a clinical assessment by a prescriber — you cannot legally buy it "over the counter" or without a prescription. The usual private route is straightforward: you complete a free online eligibility check, a GPhC-registered pharmacist prescriber reviews your answers and confirms whether it's clinically appropriate, and if it is, your first pen is dispensed and posted to you discreetly. At The Weight Clinic, Mounjaro starts from £125 a month, with no subscription and no lock-in.

That's the whole route in two sentences. The rest of this guide explains each step properly — who's eligible, what the checks actually involve, what it costs, what to expect from the medicine, and the safety trade-offs you should weigh before you start.

Can you legally get Mounjaro in the UK?

Yes — but only on prescription. Mounjaro is the brand name for tirzepatide, a once-weekly injection. The Medicines and Healthcare products Regulatory Agency (MHRA) authorised it for weight management in adults on 8 November 2023, and under that authorisation it is a prescription-only medicine (POM). That legal status is the single most important thing to understand about how you get it.

In practice this means:

• No UK pharmacy, website or clinic can lawfully sell you Mounjaro without a prescriber first assessing you. If a site offers to "sell Mounjaro, no prescription needed," that's a red flag, not a shortcut.
• The prescription has to come from an appropriately qualified prescriber — a doctor, or a pharmacist independent prescriber — who has reviewed your medical information.
• The medicine must be dispensed by a registered pharmacy. In England, Scotland and Wales that means the pharmacy is on the register of the General Pharmaceutical Council (GPhC).

So the honest answer to "how do I get Mounjaro fast in the UK" is: you get it as fast as a proper assessment allows — which, done online, is often the same day. The assessment isn't a formality to click past; it's the thing that makes it legal and safe.

Am I eligible for Mounjaro? The BMI rules explained

Eligibility is where most people get confused, because there are two different sets of thresholds floating around — one for the NHS and one for the medicine's licence — and they aren't the same.

The MHRA licence (this is the basis for private prescriptions). Mounjaro is licensed for adults with a body mass index (BMI) of 30 kg/m² or above, or a BMI of 27 to 30 kg/m² where there's at least one weight-related health problem — for example type 2 diabetes or prediabetes, high blood pressure, raised cholesterol or obstructive sleep apnoea. It's licensed to be used alongside a reduced-calorie diet and increased physical activity, not instead of them.

The NHS route (NICE TA1026) is stricter. For NHS-funded treatment, the National Institute for Health and Care Excellence recommends tirzepatide only for adults with a BMI of at least 35 and at least one weight-related comorbidity, with the threshold lowered by 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds (who tend to carry weight-related health risk at a lower BMI). NHS access is also being phased in gradually.

That gap — licence BMI 27–30+ versus NHS BMI 35+ — is exactly why so many people who don't qualify for NHS treatment can still be eligible privately. It's not a loophole; it's the difference between what the medicine is licensed for and what the NHS has chosen to fund first.

A quick, honest caveat on BMI: it's a useful screening tool but a blunt one. A very muscular person can have a "high" BMI without excess fat, and BMI reads differently across body types and ethnicities. A good prescriber treats your BMI as a starting point for the conversation, not the whole verdict — which is one reason the assessment matters. The fastest way to know where you stand is our free eligibility check, which walks you through the numbers and the health questions in a few minutes.

How the online eligibility check works

The private online route has four stages, and none of them should feel like a hoop to jump through — each one exists to make sure the medicine is right for you.

1. The free eligibility check. You answer questions about your height and weight (which gives your BMI), your medical history, current medications, and any relevant conditions. This is free, takes a few minutes, and there's no payment or commitment at this stage. You're simply finding out whether it's worth going further.

2. Clinical assessment by a prescriber. This is the part that a legitimate service will never skip. A GPhC-registered pharmacist independent prescriber reviews your answers against the clinical criteria and your safety profile. At The Weight Clinic that assessment is overseen by our Superintendent Pharmacist, Andrew Lane (GPhC 2027876), working alongside our Pharmacist Independent Prescriber, Fatma Al Sibahi (GPhC 2232235). The prescriber is checking for the things that make Mounjaro unsafe or unsuitable for you specifically — not just ticking your BMI.

3. Prescription and dispensing. If Mounjaro is appropriate, the prescriber issues a private prescription and the pharmacy dispenses it. If it isn't appropriate — because of a contraindication, an interaction, or because your numbers don't meet the licence — a responsible service tells you no, and often points you somewhere more suitable. "No" is sometimes the right clinical answer, and you should be wary of any provider that never says it.

4. Discreet delivery. Your pen is packed and posted in plain, unbranded packaging, typically on a next-day tracked service. You start at the lowest dose (2.5 mg once weekly) and step up gradually over the following weeks, which is how the tolerability is managed.

You can start the eligibility check here whenever you're ready — it's the same free first step regardless of which treatment turns out to suit you.

How much does Mounjaro cost in the UK?

Privately, Mounjaro at The Weight Clinic starts from £125 per month. There's no subscription, no joining fee and no contract — you order when you're ready to reorder, and you stop whenever you choose.

The dose you're on affects the price, because Mounjaro comes in strengths from 2.5 mg up to 15 mg and you titrate upward over time. Everyone starts low, so early months are typically at the lower end. Across the private market UK prices vary quite a bit, and it's worth reading the small print: a headline price that turns out to be a locked-in monthly subscription, or that jumps sharply at higher doses, isn't always the bargain it looks like.

Mounjaro is one of a few options we offer, and the right one depends on your goals, budget and how your body responds. If you're weighing it against alternatives, it's worth reading up on Wegovy (semaglutide) and the newer oral option, the Wegovy pill, or comparing all of the weight-loss injections side by side. You can see the full range on our treatments page.

How well does Mounjaro work?

This is where honesty matters, because the numbers are genuinely strong — and precisely because they're strong, they're easy to overstate.

The pivotal trial for tirzepatide in weight management was SURMOUNT-1, published in the New England Journal of Medicine in 2022. In adults with obesity (without type 2 diabetes), those on the highest 15 mg dose lost, on average, 22.5% of their body weight over 72 weeks — roughly 24 kg — alongside a reduced-calorie diet and increased physical activity. That 22.5% is the efficacy estimand (what people lost while actually taking the medicine as intended); on the more conservative treatment-regimen estimand (counting everyone regardless of whether they stopped) the average was about 20.9%. Lower doses produced smaller average losses — around 16% at 5 mg.

Two things to hold onto about those figures. First, results vary, and not everyone reaches them — these are averages from a trial, achieved over nearly a year and a half, alongside a reduced-calorie diet and increased activity and with structured lifestyle support around it. Some people lose more, some noticeably less, and some don't tolerate the medicine at all. Second, it was measured with diet and physical activity, not as a substitute for them. Mounjaro reduces appetite and helps you eat less without constant hunger; the eating and moving still have to happen.

For context, tirzepatide's trial average is higher than semaglutide's: in the STEP-1 trial (NEJM, 2021), Wegovy (semaglutide 2.4 mg) produced a mean weight loss of 14.9% over 68 weeks (versus about 2.4% on placebo), again alongside a reduced-calorie diet and increased activity — and, as with any trial average, results vary and not everyone reaches it. That doesn't automatically make Mounjaro "better for you" — tolerability, cost, availability and how your own body responds all feed into the right choice, which is exactly the kind of thing the assessment is there to talk through.

Mounjaro side effects and safety — the balanced view

No effective medicine is free of trade-offs, and Mounjaro is no exception. You should go in knowing both the common nuisances and the rare-but-serious risks.

Common side effects. Most are gastrointestinal and tend to be worst when you start a dose and then settle. They include:

• Nausea
• Diarrhoea
• Vomiting
• Constipation

These are usually mild to moderate and improve over time, which is partly why the dose is increased slowly rather than all at once. Eating smaller, lower-fat meals and staying hydrated helps many people through the early weeks.

Serious but less common risks. These are rarer, but you need to know them:

• Acute pancreatitis (inflammation of the pancreas). The MHRA describes this as a known but infrequent risk with these medicines, with rare severe or necrotising cases. The red flag to act on is severe, persistent abdominal pain that radiates through to your back, often with nausea or vomiting — if that happens, stop the medicine and seek urgent medical care.
• Gallbladder problems, including gallstones, which can occur with rapid weight loss.
• Dehydration and kidney effects, usually linked to persistent vomiting or diarrhoea.
• Low blood sugar (hypoglycaemia), more relevant if you also take medicines for diabetes such as insulin or sulfonylureas.

Who shouldn't take it. Mounjaro isn't suitable for everyone. It's not for use in pregnancy or while breastfeeding or trying to conceive, and it's contraindicated if you have a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). There are also cautions around a history of pancreatitis and certain gastrointestinal and other conditions. It can also affect how other medicines — including the oral contraceptive pill — are absorbed. Screening for exactly these issues is the whole point of the prescriber assessment, and it's why the online questionnaire asks what it asks.

Reporting problems. If you experience a side effect, you can report it directly to the MHRA through the Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app. Reporting helps the regulator monitor the safety of medicines in real-world use — it's genuinely worth doing.

None of this is meant to scare you off. For eligible people, Mounjaro is a well-studied, MHRA-authorised treatment with strong trial results. The point is simply that "effective" and "risk-free" aren't the same thing, and a good clinic will make sure you understand both sides before you start.

How it works at The Weight Clinic

We've tried to make the route simple without cutting the corners that matter. You start with a free online eligibility check. If it looks like Mounjaro could suit you, one of our GPhC-registered prescribers — with oversight from Superintendent Pharmacist Andrew Lane (GPhC 2027876) — reviews your full clinical picture before anything is prescribed. If it's appropriate, your first pen is dispensed and posted discreetly, usually next day. Mounjaro starts from £125 a month, there's no subscription, and you're never locked in.

If you'd like to find out where you stand, the first step is free and takes a few minutes.

Check your eligibility →

Frequently asked questions

Can I get Mounjaro without a prescription in the UK? No. Mounjaro (tirzepatide) is a prescription-only medicine. It can only be supplied after a prescriber has assessed you and decided it's clinically appropriate, and it must be dispensed by a registered pharmacy. Any service claiming to sell it without a prescription is operating unlawfully, and buying medicine that way carries real safety risks.

How quickly can I start Mounjaro? Through the online route it can be fast — often the same day — because the eligibility check and prescriber assessment can happen quickly. But "fast" still means after a proper clinical assessment, never instead of one. If you're eligible and there are no red flags, your first pen is typically dispatched on a next-day tracked service.

Do I qualify for Mounjaro on the NHS? Possibly, but the NHS bar is higher than the private one. NICE (TA1026) recommends tirzepatide on the NHS for adults with a BMI of at least 35 plus a weight-related condition (2.5 lower for some ethnic backgrounds), and access is being rolled out in phases. Many people who don't meet the NHS criteria still qualify privately, because the medicine's MHRA licence starts at a BMI of 30 (or 27 with a weight-related condition).

How much weight will I actually lose on Mounjaro? Results vary and no one can promise a number. In the SURMOUNT-1 trial, adults on the highest 15 mg dose lost an average of 22.5% of their body weight over 72 weeks, alongside diet and activity changes — but that's a trial average over nearly a year and a half. Some people lose more, some less, and lifestyle changes remain part of the picture.

Is Mounjaro or Wegovy better? Neither is universally "better." In their pivotal trials, tirzepatide (Mounjaro) averaged higher weight loss than semaglutide (Wegovy) — around 22.5% versus 14.9%, each alongside a reduced-calorie diet and increased activity. Those are trial averages, results vary and not everyone reaches them, and the right choice depends on your health, budget, tolerability and how you respond. It's a decision to make with a prescriber; comparing the treatment options is a good starting point.

What are the main side effects I should watch for? The common ones are gastrointestinal — nausea, diarrhoea, vomiting and constipation — usually mildest once your body adjusts. Rarer but serious risks include pancreatitis and gallbladder problems. If you get severe, persistent tummy pain, seek urgent medical help, and report any side effect to the MHRA via the Yellow Card scheme.